New RSV shot for infants shows promise in Real-World study

NCT ID NCT07109297

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 26 times

Summary

This study looks at how safe and effective nirsevimab is at preventing severe RSV in babies and toddlers up to 24 months old. About 110 children will receive the medicine as part of their regular care. Researchers will track any side effects and how many children get sick with RSV.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RSV IMMUNIZATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Investigational Site Number : 3560001

    New Delhi, 110060, India

  • Investigational Site Number : 3560002

    Bengaluru, 560011, India

  • Investigational Site Number : 3560003

    Kolkata, 700017, India

  • Investigational Site Number : 3560004

    Pune, 411007, India

  • Investigational Site Number : 3560006

    Vizianagaram, 535003, India

  • Investigational Site Number : 3560007

    Nagpur, 441108, India

  • Investigational Site Number : 3560008

    Jaipur, 302007, India

Conditions

Explore the condition pages connected to this study.